Document Detail

New developments in medical-surgical treatment of acute myocardial infarction.
MedLine Citation:
PMID:  6185094     Owner:  NLM     Status:  MEDLINE    
Selective intracoronary thrombolysis with streptokinase was successful in 72 of 84 (86%) patients admitted to the hospital with definitive signs of acute transmural myocardial infarction due to complete occlusion of either the left anterior descending coronary artery, the right coronary artery, or the circumflex artery. The average time between onset of acute symptoms and medically induced reperfusion was 241 +/- 90 minutes (SD). Reperfusion resulted in prompt relief of pain, regression of cardiogenic shock, and normalization of electrocardiograms. Follow-up treatment was either medical or surgical. The 32 medically treated patients had a high reocclusion rate, with 6 fatal (19%) and 9 nonfatal (28%) reinfarctions. In order to the reduce the risk of reinfarction, additional simultaneous transluminal balloon angioplasty was done in a recent series of patients with stenoses accessible to this technique. The best early and long-term results were achieved in 17 patients who underwent coronary artery bypass grafting within three days after successful thrombolysis. There was no operative mortality, and subsequent bleeding has not been a problem. It is concluded that early operation is the treatment of choice in all patients suitable for such intervention who have undergone successful intracoronary thrombolysis within 4 hours after onset of acute myocardial infarction. Late coronary bypass operation should be reserved for symptomatic patients who have definitive signs of infarction in spite of successful thrombolysis.
B J Messmer; W Merx; J Meyer; P Bardos; C Minale; S Effert
Related Documents :
17587714 - Improvement of postprandial hyperglycemia has a positive impact on epicardial flow of e...
9266784 - Significance of the thrombolysis in myocardial infarction scoring system in assessing i...
17851974 - Near-normal coronary angiography in a patient, who is entirely asymptomatic 24 years af...
21292844 - Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial ...
1790164 - The heart in muscular dystrophy: an electrocardiographic and ultrasound study of 20 pat...
25468914 - Heart failure with preserved ejection fraction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  35     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1983 Jan 
Date Detail:
Created Date:  1983-02-14     Completed Date:  1983-02-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  70-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon
Coronary Angiography
Coronary Artery Bypass* / mortality
Dextrans / administration & dosage*
Fibrinolytic Agents / therapeutic use
Follow-Up Studies
Heart Catheterization
Middle Aged
Myocardial Infarction / drug therapy,  surgery,  therapy*
Time Factors
Reg. No./Substance:
0/Fibrinolytic Agents; 9004-54-0/Dextrans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Urinary beta-2-microglobulin does not serve as diagnostic tool for Minamata disease.
Next Document:  A reappraisal of antigenic determinants for nitrogenase from Azotobacter and nitrate reductase from ...